Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Benefits of combining prevalent and incident cohorts: An application to myotonic dystrophy.

Wolfson DB, Best AF, Addona V, Wolfson J, Gadalla SM.

Stat Methods Med Res. 2018 Oct 8:962280218804275. doi: 10.1177/0962280218804275. [Epub ahead of print]

PMID:
30293502
2.

Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow allografts have improved Long-term Overall and Graft-versus-Host Disease, Relapse-Free Survival.

Alousi A, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel DR, Pidala J, Anderlini PN, Boyiadzis M, Bredeson CN, Cahn JY, Cairo MS, Gadalla SM, Hashmi SK, Gale RP, Kanda J, Kamble RT, Kharfan-Dabaja MA, Litzow MR, Ringden O, Saad AA, Schultz KR, Verdonck LF, Waller EK, Yared JA, Holtan SG, Weisdorf DJ.

Biol Blood Marrow Transplant. 2018 Oct 3. pii: S1083-8791(18)30561-5. doi: 10.1016/j.bbmt.2018.09.004. [Epub ahead of print]

PMID:
30292009
3.

The Effect of Cancer Treatments on Telomere Length: A Systematic Review of the Literature.

Gallicchio L, Gadalla SM, Murphy JD, Simonds NI.

J Natl Cancer Inst. 2018 Oct 1;110(10):1048-1058. doi: 10.1093/jnci/djy189.

PMID:
30272225
4.

Survival patterns and cancer determinants in families with myotonic dystrophy type 1.

Best AF, Hilbert JE, Wood L, Martens WB, Nikolenko N, Marini-Bettolo C, Lochmüller H, Rosenberg PS, Moxley RT 3rd, Greene MH, Gadalla SM.

Eur J Neurol. 2018 Jul 27. doi: 10.1111/ene.13763. [Epub ahead of print]

PMID:
30051542
5.

Cancer phenotype in myotonic dystrophy patients: Results from a meta-analysis.

Emparanza JI, López de Munain A, Greene MH, Matheu A, Fernández-Torrón R, Gadalla SM.

Muscle Nerve. 2018 Oct;58(4):517-522. doi: 10.1002/mus.26194.

PMID:
30028904
6.

Chromosomal Aberrations and Survival after Unrelated Donor Hematopoietic Stem Cell Transplant in Patients with Fanconi Anemia.

Wang Y, Zhou W, Alter BP, Wang T, Spellman SR, Haagenson M, Yeager M, Lee SJ, Chanock SJ, Savage SA, Gadalla SM.

Biol Blood Marrow Transplant. 2018 Jun 4. pii: S1083-8791(18)30309-4. doi: 10.1016/j.bbmt.2018.05.027. [Epub ahead of print]

PMID:
29879518
7.

Similar telomere attrition rates in androgen-treated and untreated patients with dyskeratosis congenita.

Khincha PP, Bertuch AA, Gadalla SM, Giri N, Alter BP, Savage SA.

Blood Adv. 2018 Jun 12;2(11):1243-1249. doi: 10.1182/bloodadvances.2018016964.

8.

Risk factors for Burkitt lymphoma: a nested case-control study in the UK Clinical Practice Research Datalink.

Karimi P, Birmann BM, Anderson LA, McShane CM, Gadalla SM, Sampson JN, Mbulaiteye SM.

Br J Haematol. 2018 May;181(4):505-514. doi: 10.1111/bjh.15229. Epub 2018 Apr 20.

PMID:
29676453
9.

Donor telomere length and causes of death after unrelated hematopoietic cell transplantation in patients with marrow failure.

Gadalla SM, Aubert G, Wang T, Haagenson M, Spellman SR, Wang L, Katki HA, Savage SA, Lee SJ.

Blood. 2018 May 24;131(21):2393-2398. doi: 10.1182/blood-2017-10-812735. Epub 2018 Apr 9.

PMID:
29632022
10.

Lipid-lowering drugs, dyslipidemia, and breast cancer risk in a Medicare population.

Schairer C, Freedman DM, Gadalla SM, Pfeiffer RM.

Breast Cancer Res Treat. 2018 Jun;169(3):607-614. doi: 10.1007/s10549-018-4680-7. Epub 2018 Feb 15.

PMID:
29450675
11.

Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation.

Turcotte LM, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Ahmed I, Beitinjaneh A, Buchbinder D, Byrne M, Callander N, Chao N, Choi SW, DeFilipp Z, Gadalla SM, Gale RP, Gergis U, Hashmi S, Hematti P, Holmberg L, Inamoto Y, Kamble RT, Lehmann L, MacMillan MA, McIver Z, Nishihori T, Norkin M, O'Brien T, Olsson RF, Reshef R, Saad A, Savani BN, Schouten HC, Seo S, Solh M, Verdonck L, Vij R, Wirk B, Yared J, Horowitz MM, Knight JM, Verneris MR.

Bone Marrow Transplant. 2018 Jul;53(7):932-937. doi: 10.1038/s41409-018-0100-1. Epub 2018 Jan 30. No abstract available.

12.

No association between donor telomere length and outcomes after allogeneic unrelated hematopoietic cell transplant in patients with acute leukemia.

Gadalla SM, Wang T, Loftus D, Friedman L, Dagnall C, Haagenson M, Spellman SR, Buturovic L, Blauwkamp M, Shelton J, Fleischhauer K, Hsu KC, Verneris MR, Krstajic D, Hicks B, Jones K, Lee SJ, Savage SA.

Bone Marrow Transplant. 2018 Apr;53(4):383-391. doi: 10.1038/s41409-017-0029-9. Epub 2017 Dec 21.

13.

Autoimmune diseases and breast cancer risk by tumor hormone-receptor status among elderly women.

Schairer C, Pfeiffer RM, Gadalla SM.

Int J Cancer. 2018 Mar 15;142(6):1202-1208. doi: 10.1002/ijc.31148. Epub 2017 Nov 24.

PMID:
29144542
14.

Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink.

Wang Y, Pfeiffer RM, Alsaggaf R, Meeraus W, Gage JC, Anderson LA, Bremer RC, Nikolenko N, Lochmuller H, Greene MH, Gadalla SM.

Int J Cancer. 2018 Mar 15;142(6):1174-1181. doi: 10.1002/ijc.31143. Epub 2017 Nov 20.

PMID:
29114849
15.

Editorial: US Cancer Statistics of Survival: Achievements, Challenges, and Future Directions.

Gadalla SM, Widemann BC.

J Natl Cancer Inst. 2017 Sep 1;109(9). doi: 10.1093/jnci/djx070. No abstract available.

16.

Effect of pre-analytic variables on the reproducibility of qPCR relative telomere length measurement.

Dagnall CL, Hicks B, Teshome K, Hutchinson AA, Gadalla SM, Khincha PP, Yeager M, Savage SA.

PLoS One. 2017 Sep 8;12(9):e0184098. doi: 10.1371/journal.pone.0184098. eCollection 2017.

17.

Correlation of Leukocyte Telomere Length Measurement Methods in Patients with Dyskeratosis Congenita and in Their Unaffected Relatives.

Khincha PP, Dagnall CL, Hicks B, Jones K, Aviv A, Kimura M, Katki H, Aubert G, Giri N, Alter BP, Savage SA, Gadalla SM.

Int J Mol Sci. 2017 Aug 13;18(8). pii: E1765. doi: 10.3390/ijms18081765.

18.

Benign and malignant tumors in the UK myotonic dystrophy patient registry.

Alsaggaf R, Wang Y, Marini-Bettolo C, Wood L, Nikolenko N, Lochmüller H, Greene MH, Gadalla SM.

Muscle Nerve. 2018 Feb;57(2):316-320. doi: 10.1002/mus.25736. Epub 2017 Jul 24.

PMID:
28662292
19.

Hematopoietic Stem Cell Transplantation Activity in Pediatric Cancer between 2008 and 2014 in the United States: A Center for International Blood and Marrow Transplant Research Report.

Khandelwal P, Millard HR, Thiel E, Abdel-Azim H, Abraham AA, Auletta JJ, Boulad F, Brown VI, Camitta BM, Chan KW, Chaudhury S, Cowan MJ, Angel-Diaz M, Gadalla SM, Gale RP, Hale G, Kasow KA, Keating AK, Kitko CL, MacMillan ML, Olsson RF, Page KM, Seber A, Smith AR, Warwick AB, Wirk B, Mehta PA.

Biol Blood Marrow Transplant. 2017 Aug;23(8):1342-1349. doi: 10.1016/j.bbmt.2017.04.018. Epub 2017 Apr 24.

20.

Telomeres and the natural lifespan limit in humans.

Steenstrup T, Kark JD, Verhulst S, Thinggaard M, Hjelmborg JVB, Dalgård C, Kyvik KO, Christiansen L, Mangino M, Spector TD, Petersen I, Kimura M, Benetos A, Labat C, Sinnreich R, Hwang SJ, Levy D, Hunt SC, Fitzpatrick AL, Chen W, Berenson GS, Barbieri M, Paolisso G, Gadalla SM, Savage SA, Christensen K, Yashin AI, Arbeev KG, Aviv A.

Aging (Albany NY). 2017 Apr;9(4):1130-1142. doi: 10.18632/aging.101216.

21.

Relative Telomere Length before Hematopoietic Cell Transplantation and Outcome after Unrelated Donor Hematopoietic Cell Transplantation for Acute Leukemia.

Wang Y, Wang T, Dagnall C, Haagenson M, Spellman SR, Hicks B, Jones K, Lee SJ, Savage SA, Gadalla SM.

Biol Blood Marrow Transplant. 2017 Jul;23(7):1054-1058. doi: 10.1016/j.bbmt.2017.03.032. Epub 2017 Apr 4.

22.

Pigmentation phenotype, photosensitivity and skin neoplasms in patients with myotonic dystrophy.

Gadalla SM, Hilbert JE, Martens WB, Givens S, Moxley RT 3rd, Greene MH.

Eur J Neurol. 2017 May;24(5):713-718. doi: 10.1111/ene.13276. Epub 2017 Mar 20.

23.

Diabetes, Abnormal Glucose, Dyslipidemia, Hypertension, and Risk of Inflammatory and Other Breast Cancer.

Schairer C, Gadalla SM, Pfeiffer RM, Moore SC, Engels EA.

Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):862-868. doi: 10.1158/1055-9965.EPI-16-0647. Epub 2017 Jan 13.

24.

Effect of Recipient Age and Stem Cell Source on the Association between Donor Telomere Length and Survival after Allogeneic Unrelated Hematopoietic Cell Transplantation for Severe Aplastic Anemia.

Gadalla SM, Wang T, Dagnall C, Haagenson M, Spellman SR, Hicks B, Jones K, Katki HA, Lee SJ, Savage SA.

Biol Blood Marrow Transplant. 2016 Dec;22(12):2276-2282. doi: 10.1016/j.bbmt.2016.09.012. Epub 2016 Sep 15.

25.

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report.

Morton LM, Saber W, Baker KS, Barrett AJ, Bhatia S, Engels EA, Gadalla SM, Kleiner DE, Pavletic S, Burns LJ.

Biol Blood Marrow Transplant. 2017 Mar;23(3):367-378. doi: 10.1016/j.bbmt.2016.09.005. Epub 2016 Sep 12.

26.

The limitations of qPCR telomere length measurement in diagnosing dyskeratosis congenita.

Gadalla SM, Khincha PP, Katki HA, Giri N, Wong JY, Spellman S, Yanovski JA, Han JC, De Vivo I, Alter BP, Savage SA.

Mol Genet Genomic Med. 2016 Mar 20;4(4):475-9. doi: 10.1002/mgg3.220. eCollection 2016 Jul.

27.

Erratum to: Increased risk of tumor in DM1 is not related to exposure to common lifestyle risk factors.

Bianchi ML, Leoncini E, Masciullo M, Modoni A, Gadalla SM, Massa R, Botta A, Rastelli E, Terracciano C, Antonini G, Bucci E, Petrucci A, Costanzi S, Santoro M, Boccia S, Silvestri G.

J Neurol. 2016 Mar;263(3):499. doi: 10.1007/s00415-016-8068-5. No abstract available.

PMID:
26914929
28.

Polychlorinated Biphenyls and Cancer: Are Telomeres to Blame?

Gadalla SM, Andreotti G.

EBioMedicine. 2015 Dec 15;2(12):1856-7. doi: 10.1016/j.ebiom.2015.12.011. eCollection 2015 Dec. No abstract available.

29.

Increased risk of tumor in DM1 is not related to exposure to common lifestyle risk factors.

Bianchi ML, Leoncini E, Masciullo M, Modoni A, Gadalla SM, Massa R, Rastelli E, Terracciano C, Antonini G, Bucci E, Petrucci A, Costanzi S, Santoro M, Boccia S, Silvestri G.

J Neurol. 2016 Mar;263(3):492-8. doi: 10.1007/s00415-015-8006-y. Epub 2016 Jan 6. Erratum in: J Neurol. 2016 Mar;263(3):499.

PMID:
26739382
30.

Brain tumors in patients with myotonic dystrophy: a population-based study.

Gadalla SM, Pfeiffer RM, Kristinsson SY, Björkholm M, Landgren O, Greene MH.

Eur J Neurol. 2016 Mar;23(3):542-7. doi: 10.1111/ene.12886. Epub 2015 Oct 28.

PMID:
26508558
31.

Pesticide Use and Relative Leukocyte Telomere Length in the Agricultural Health Study.

Andreotti G, Hoppin JA, Hou L, Koutros S, Gadalla SM, Savage SA, Lubin J, Blair A, Hoxha M, Baccarelli A, Sandler D, Alavanja M, Beane Freeman LE.

PLoS One. 2015 Jul 21;10(7):e0133382. doi: 10.1371/journal.pone.0133382. eCollection 2015.

32.

Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia.

Gadalla SM, Wang T, Haagenson M, Spellman SR, Lee SJ, Williams KM, Wong JY, De Vivo I, Savage SA.

JAMA. 2015 Feb 10;313(6):594-602. doi: 10.1001/jama.2015.7.

33.

Telomeres in molecular epidemiology studies.

Bodelon C, Savage SA, Gadalla SM.

Prog Mol Biol Transl Sci. 2014;125:113-31. doi: 10.1016/B978-0-12-397898-1.00005-0. Review.

PMID:
24993700
34.

NHANES III equations enhance early detection and mortality prediction of bronchiolitis obliterans syndrome after hematopoietic SCT.

Williams KM, Hnatiuk O, Mitchell SA, Baird K, Gadalla SM, Steinberg SM, Shelhamer J, Carpenter A, Avila D, Taylor T, Grkovic L, Pulanic D, Comis LE, Blacklock-Schuver B, Gress RE, Pavletic SZ.

Bone Marrow Transplant. 2014 Apr;49(4):561-6. doi: 10.1038/bmt.2013.222. Epub 2014 Jan 13.

35.

Quantifying cancer absolute risk and cancer mortality in the presence of competing events after a myotonic dystrophy diagnosis.

Gadalla SM, Pfeiffer RM, Kristinsson SY, Björkholm M, Hilbert JE, Moxley RT 3rd, Landgren O, Greene MH.

PLoS One. 2013 Nov 13;8(11):e79851. doi: 10.1371/journal.pone.0079851. eCollection 2013.

36.

Telomere length and risk of glioma.

Walcott F, Rajaraman P, Gadalla SM, Inskip PD, Purdue MP, Albanes D, Orr E, De Vivo I, Savage SA.

Cancer Epidemiol. 2013 Dec;37(6):935-8. doi: 10.1016/j.canep.2013.10.002. Epub 2013 Nov 11.

37.

Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita.

Gadalla SM, Sales-Bonfim C, Carreras J, Alter BP, Antin JH, Ayas M, Bodhi P, Davis J, Davies SM, Deconinck E, Deeg HJ, Duerst RE, Fasth A, Ghavamzadeh A, Giri N, Goldman FD, Kolb EA, Krance R, Kurtzberg J, Leung WH, Srivastava A, Or R, Richman CM, Rosenberg PS, Toledo Codina JS, Shenoy S, Socié G, Tolar J, Williams KM, Eapen M, Savage SA.

Biol Blood Marrow Transplant. 2013 Aug;19(8):1238-43. doi: 10.1016/j.bbmt.2013.05.021. Epub 2013 Jun 8.

38.

Bcl-2 level as a biomarker for 13q14 deletion in CLL.

Degheidy HA, Gadalla SM, Farooqui MZ, Abbasi F, Arthur DC, Bauer SR, Wilson WH, Wiestner A, Stetler-Stevenson MA, Marti GE.

Cytometry B Clin Cytom. 2013 Jul-Aug;84(4):237-47. doi: 10.1002/cyto.b.21090. Epub 2013 May 14.

39.

The long and short of telomeres and cancer association studies.

Savage SA, Gadalla SM, Chanock SJ.

J Natl Cancer Inst. 2013 Apr 3;105(7):448-9. doi: 10.1093/jnci/djt041. Epub 2013 Mar 6. No abstract available.

40.

Enhancing a cancer prevention and control curriculum through interactive group discussions.

Forsythe LP, Gadalla SM, Hamilton JG, Heckman-Stoddard BM, Kent EE, Lai GY, Lin SW, Luhn P, Faupel-Badger JM.

J Cancer Educ. 2012 Jun;27(3):428-35. doi: 10.1007/s13187-012-0376-6.

41.

Correlates of tumor development in patients with myotonic dystrophy.

Das M, Moxley RT 3rd, Hilbert JE, Martens WB, Letren L, Greene MH, Gadalla SM.

J Neurol. 2012 Oct;259(10):2161-6. doi: 10.1007/s00415-012-6476-8. Epub 2012 May 23.

42.

Cancer risk among patients with myotonic muscular dystrophy.

Gadalla SM, Lund M, Pfeiffer RM, Gørtz S, Mueller CM, Moxley RT 3rd, Kristinsson SY, Björkholm M, Shebl FM, Hilbert JE, Landgren O, Wohlfahrt J, Melbye M, Greene MH.

JAMA. 2011 Dec 14;306(22):2480-6. doi: 10.1001/jama.2011.1796.

43.

The relationship between DNA methylation and telomere length in dyskeratosis congenita.

Gadalla SM, Katki HA, Shebl FM, Giri N, Alter BP, Savage SA.

Aging Cell. 2012 Feb;11(1):24-8. doi: 10.1111/j.1474-9726.2011.00755.x. Epub 2011 Nov 15.

44.

Telomere biology in hematopoiesis and stem cell transplantation.

Gadalla SM, Savage SA.

Blood Rev. 2011 Nov;25(6):261-9. doi: 10.1016/j.blre.2011.06.004. Epub 2011 Jul 20. Review.

PMID:
21764192
45.

Telomere length in blood, buccal cells, and fibroblasts from patients with inherited bone marrow failure syndromes.

Gadalla SM, Cawthon R, Giri N, Alter BP, Savage SA.

Aging (Albany NY). 2010 Nov;2(11):867-74.

46.

A population-based assessment of mortality and morbidity patterns among patients with thymoma.

Gadalla SM, Rajan A, Pfeiffer R, Kristinsson SY, Björkholm M, Landgren O, Giaccone G.

Int J Cancer. 2011 Jun 1;128(11):2688-94. doi: 10.1002/ijc.25583. Epub 2010 Jul 28.

47.

LINE-1 methylation is inherited in familial testicular cancer kindreds.

Mirabello L, Savage SA, Korde L, Gadalla SM, Greene MH.

BMC Med Genet. 2010 May 17;11:77. doi: 10.1186/1471-2350-11-77.

48.

Correlates of high hepatitis C virus RNA load in a cohort of HIV-negative and HIV-positive individuals with haemophilia.

Gadalla SM, Preiss LR, Eyster ME, Goedert JJ.

J Viral Hepat. 2011 Mar;18(3):161-9. doi: 10.1111/j.1365-2893.2010.01289.x.

49.

Evidence-based care for breast cancer survivors: communicating the Institute of Medicine Guidelines in medical practice.

Royak-Schaler R, Gardner LD, Shardell M, Zhan M, Passmore SR, Gadalla SM, Hoy MK, Tkaczuk KH, Nesbitt K.

Patient Educ Couns. 2009 Dec;77(3):413-20. doi: 10.1016/j.pec.2009.09.042. Epub 2009 Nov 2.

PMID:
19883985
50.

Cancer risk assessment for the primary care physician.

Korde LA, Gadalla SM.

Prim Care. 2009 Sep;36(3):471-88. doi: 10.1016/j.pop.2009.04.006.

Supplemental Content

Loading ...
Support Center